All In Biotech

Free tool

Drugs in development

Investigational drugs and biologics in industry-sponsored Phase 2 and Phase 3 trials that are active or finished in the last two years, and that FDA has not approved. Built from 10,322 ClinicalTrials.gov records, with code names and generic names merged. For approved drugs, use Drug Search.

Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations

Drugs in development

3,685

Not FDA-approved

In Phase 3

1,424

Highest phase reached

Matching your filters

45

Reset

45 drugs in development

Names, sponsors and conditions come from the trial records. Click a drug for its trials.

  • SKB264MK-2870, Sacituzumab TirumotecanPhase 353 trials

    Merck & Co. · Non-Small Cell Lung Cancer, Non-small Cell Lung Cancer, Cervical Cancer

  • BMS-986507BL-B01D1, Iza-brenPhase 351 trials

    Sichuan Baili Pharmaceutical Co., Ltd. · Non-small Cell Lung Cancer, Solid Tumor, Urothelial Carcinoma

  • CadonilimabAK104Phase 331 trials

    Akeso · Hepatocellular Carcinoma, Gastric / Gastroesophageal Junction Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma

  • SHR-A1811Trastuzumab RezetecanPhase 327 trials

    Jiangsu HengRui Medicine Co., Ltd. · Advanced Colorectal Cancer, Recurrent or Metastatic Cervical Cancer, Ovarian Cancer

  • AdabelimumabSHR-A2102, SHR2554Phase 320 trials

    Suzhou Suncadia Biopharmaceuticals Co., Ltd. · Advanced Solid Tumors, Prostate Cancer, Advanced Urothelial Carcinoma

  • VolrustomigMEDI5752Phase 313 trials

    AstraZeneca · Gastric Cancer, Non-small Cell Lung Cancer, Biliary Tract Cancer

  • ZimberelimabAB122, GS-0122Phase 312 trials

    Gilead Sciences · Lung Cancer, Non Small Cell Lung Cancer, Nonsquamous Non Small Cell Lung Cancer

  • 9MW2821Phase 311 trials

    Mabwell (Shanghai) Bioscience Co., Ltd. · Urothelial Carcinoma, Advanced Urothelial Carcinoma, Locally Advanced or Metastatic Triple-negative Breast Cancer

  • ZG005Phase 311 trials

    Suzhou Zelgen Biopharmaceuticals Co.,Ltd · Advanced Solid Tumor, Lymphoma, Non-small Cell Lung Cancer

  • CamrelizumabSHR-1210, CAMPhase 39 trials

    Jiangsu HengRui Medicine Co., Ltd. · HCC, Non-squamous Non-small Cell Lung Cancer, Hepatocellular Carcinoma

  • GEMPhase 35 trials

    Shenzhen Majory Biotechnology Co., Ltd. · Pancreatic Ductal Adenocarcinoma (PDAC), Pancreatic Cancer, Recurrent or Metastatic Cervical Cancer

  • SYS6002Phase 35 trials

    CSPC Megalith Biopharmaceutical Co.,Ltd. · Urothelial Carcinoma, Cervical Cancer, Advanced Solid Tumors

  • JSKN033Phase 34 trials

    Jiangsu Alphamab Biopharmaceuticals Co., Ltd · Cervical Cancer, Recurrent or Metastatic Cervical Cancer, Advanced Malignant Tumors

  • WX390WXFL10030390Phase 33 trials

    Shanghai Jiatan Pharmatech Co., Ltd · Gastric Type Adenocarcinoma (GAS) With STK11 Mutation, Cervical Cancer Metastatic, Solid Tumor

  • BAT1308Recombinant humanized anti-PD-1 monoclonal antibodyPhase 32 trials

    Bio-Thera Solutions · Cervical Cancer, Advanced Solid Tumors

  • GLS-010Phase 32 trials

    Guangzhou Gloria Biosciences Co., Ltd. · Solid Tumor, Persistent, Recurrent, or Metastatic Cervical Cancer

  • LB1410Phase 32 trials

    L & L Bio Co., Ltd., Ningbo, China · Solid Tumor, Cervical Cancer

  • LB4330Phase 32 trials

    L & L Bio Co., Ltd., Ningbo, China · Solid Tumor, Cervical Cancer

  • XNW28012Phase 32 trials

    Evopoint Biosciences Inc. · Pancreatic Cancer, Advanced Solid Tumors, Pancreatic Carcinoma

  • Jiangsu HengRui Medicine Co., Ltd. · Cervical Cancer

  • RulonilimabPhase 31 trial

    Shandong New Time Pharmaceutical Co., LTD · Cervical Cancer

  • SocazolimabPhase 31 trial

    Lee's Pharmaceutical Limited · Cervical Cancer

  • GecacitinibPhase 24 trials

    Suzhou Zelgen Biopharmaceuticals Co.,Ltd · Lymphoma, Non-small Cell Lung Cancer, Advanced Solid Tumor

  • IL-2MDNA11, Interleukin-2 -albuminPhase 24 trials

    Grit Biotechnology · Advanced Solid Tumor, Unresectable Solid Tumor, Clear Cell Renal Cell Carcinoma

  • GV20-0251Phase 23 trials

    GV20 Therapeutics · Endometrial Carcinoma (EC), Squamous Head and Neck Carcinoma, pMMR/MSS Adenocarcinoma of the Colon or Rectum

  • PD-L1 t-haNKPhase 23 trials

    ImmunityBio, Inc. · Pancreatic Cancer, Non-Small Cell Lung Cancer, Small Cell Lung Cancer

  • AdebelimabPhase 22 trials

    Shanghai Hengrui Pharmaceutical Co., Ltd. · Advanced Solid Tumors, Recurrent or Metastatic Cervical Cancer

  • B1962Phase 22 trials

    Tasly Biopharmaceuticals Co., Ltd. · Recurrent Platinum-resistant Epithelial Ovarian Cancer, Triple Negative Breast Cancer (TNBC), Cervical Cancers

  • ImzokitugBMS-986340Phase 22 trials

    Bristol Myers Squibb · Locally Advanced Non-Small Cell Lung Cancer (NSCLC), Metastatic Non-Small Cell Lung Cancer (NSCLC), Cervical Cancer

  • vudalimabPhase 22 trials

    Xencor, Inc. · Ovarian Cancer, Clear Cell Carcinoma, Endometrial Cancer

  • CR-002Phase 21 trial

    Crescent Biopharma, Inc. · Head and Neck Squamous Cell Carcinoma (HNSCC) - Recurrent/Metastatic (R/M), Gastric/GEJ, Biliary Tract Cancer (BTC)

  • FamitinibSHR-1020Phase 21 trial

    Jiangsu HengRui Medicine Co., Ltd. · Recurrent or Metastatic Cervical Cancer

  • GI-101Phase 21 trial

    GI Innovation, Inc. · Advanced Solid Tumor, Metastatic Solid Tumor, Cervical Cancer

  • GI-101APhase 21 trial

    GI Innovation, Inc. · Advanced Solid Tumor, Metastatic Solid Tumor, Cervical Cancer

  • GM103Phase 21 trial

    GeneMedicine Co., Ltd. · Head and Neck Cancer, Malignant Melanoma, Colorectal Cancer

  • GT101Phase 21 trial

    Grit Biotechnology · Recurrent or Metastatic Cervical Cancer

  • HMBD-001Phase 21 trial

    Hummingbird Bioscience · Advanced or Metastatic Squamous Non-Small Cell Lung Cancer, Advanced Head and Neck Squamous Cell Carcinoma, Advanced Esophageal Squamous Cell Carcinoma

  • MDX2001Phase 21 trial

    ModeX Therapeutics, An OPKO Health Company · Biliary Tract Cancer, Breast Cancer, Cervical Cancer

  • MT-4561Phase 21 trial

    Tanabe Pharma America, Inc. · Head and Neck Squamous Cell Carcinoma (HNSCC), Non-small Cell Lung Cancer (NSCLC), Esophageal Cancer

  • NEO-201Phase 21 trial

    Precision Biologics, Inc · Non Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma, Cervical Cancer

  • NEO212POH-TMZPhase 21 trial

    Neonc Technologies, Inc. · Diffuse Astrocytoma, IDH-Mutant, Glioblastoma, IDH-wildtype, Brain Metastases, Adult

  • PRGN-2009Phase 21 trial

    Precigen, Inc · Cervical Cancer, HPV-Related Carcinoma, HPV-Related Malignancy

  • Q702Phase 21 trial

    Qurient Co., Ltd. · Esophageal Cancer, Gastric Cancer, Hepatocellular Cancer

  • SCG142Phase 21 trial

    SCG Cell Therapy Pte. Ltd. · HPV-Related Squamous Cell Carcinoma, HPV-Related Cervical Squamous Cell Carcinoma, HPV-Related Vulvar Squamous Cell Carcinoma

  • TER-2013Phase 21 trial

    Terremoto Biosciences Inc. · Breast Cancer, Endometrial Cancer, Ovarian Cancer

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.